Primary localized cutaneous amyloidosis
Last updated 24 Nov 2021
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Primary localized cutaneous amyloidosis (PLCA) is a condition in which clumps of abnormal proteins called amyloids build up in the skin, specifically in the wave-like projections (dermal papillae) between the top two layers of skin (the dermis and the epidermis). The primary feature of PLCA is patches of skin with abnormal texture or colour. The appearance of these patches defines three forms of the condition: lichen amyloidosis, macular amyloidosis, and nodular amyloidosis.
Video picks for Genetic conditionsVideo library
Description
Primary localized cutaneous amyloidosis (PLCA) is a condition in which clumps of abnormal proteins called amyloids build up in the skin, specifically in the wave-like projections (dermal papillae) between the top two layers of skin (the dermis and the epidermis). The primary feature of PLCA is patches of skin with abnormal texture or colour. The appearance of these patches defines three forms of the condition: lichen amyloidosis, macular amyloidosis, and nodular amyloidosis.
Lichen amyloidosis is characterised by severely itchy patches of thickened skin with multiple small bumps. The patches are scaly and reddish brown in colour. These patches usually occur on the shins but can also occur on the forearms, other parts of the legs, and elsewhere on the body.
In macular amyloidosis, the patches are flat and dark brown. The coloring can have a lacy (reticulated) or rippled appearance, although it is often uniform. Macular amyloidosis patches are most commonly found on the upper back, but they can also occur on other parts of the torso or on the limbs. These patches are mildly itchy.
Nodular amyloidosis is characterised by firm, raised bumps (nodules) that are pink, red, or brown. These nodules often occur on the face, torso, limbs, or genitals and are typically not itchy.
In some affected individuals, the patches have characteristics of both lichen and macular amyloidosis. These cases are called biphasic amyloidosis.
In all forms of PLCA, the abnormal patches of skin usually arise in mid-adulthood. They can remain for months to years and may recur after disappearing, either at the same location or elsewhere. Very rarely, nodular amyloidosis progresses to a life-threatening condition called systemic amyloidosis, in which amyloid deposits accumulate in tissues and organs throughout the body.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive; Not inherited; Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
Amyloidosis IX
PLCA
Primary cutaneous amyloidosis
Patient picks for Genetic conditions

Children's health
1 in 5 children starting primary school are not fully protected against serious illnesses
Around 1 in 5 children going back to school are not protected against several serious illnesses. Read here about why UK Health Security Agency (UKHSA) and NHS England urge you to check your child’s vaccination record and catch up on any missed jabs, and what illnesses the vaccinations protect against.
by Lawrence Higgins

Digestive health
Primary sclerosing cholangitis
Primary sclerosing cholangitis is an uncommon condition affecting the bile ducts and liver. Inflammation and scarring of the bile ducts can lead to liver damage and cirrhosis - a condition where normal liver tissue is replaced by scar tissue (fibrosis). Different treatments are available to control symptoms that may develop and also to manage any complications which may occur. The outlook for people with primary sclerosing cholangitis can be very variable.
by Dr Colin Tidy, MRCGP

Digestive health
Primary biliary cholangitis
Primary biliary cholangitis (PBC) is a condition that slowly damages the bile ducts in your liver, leading to liver damage and, sometimes, liver scarring (cirrhosis).
by Dr Hayley Willacy, FRCGP

Cancer
Primary bone cancer
Primary bone cancer occurs where a cancer originates in a bone. It is a rare type of cancer. There are several different types. Treatments which may be considered include surgery, chemotherapy and radiotherapy. The type of treatment used and the outlook depend on various factors including the type, site and stage of the cancer.
by Dr Rosalyn Adleman, MRCGP

Cancer
Primary liver cancer
In primary liver cancer the cancer starts in the liver. In secondary liver cancer, the cancer spreads from another part of the body to the liver. Primary liver cancer is uncommon in the UK but is common in other parts of the world. In the UK, most cases develop as a complication of scarring of the liver (cirrhosis). In general the outlook is poor. Surgery to remove the cancer is an option in a small number of cases and, if it is possible, gives the best chance of a cure.
by Dr Toni Hazell, FRCGP

Oral and dental care
Primary cold sore infection
Your first (primary) infection with the cold sore virus can seem different to the repeated (recurring) cold sores which many people have. There may be no symptoms but sometimes there can be a significant infection of your mouth. Treatment aims to ease symptoms while the infection gradually settles over 1-3 weeks.
by Dr Philippa Vincent, MRCGP
Related patient information and medicines

Patient information leaflet
Localised scleroderma
Localised scleroderma causes one or more patches of hard skin. There are different types. The common plaque type usually causes no problems (apart from sometimes an unsightly appearance) and tends to fade in time. Often no treatment is needed for the plaque type but treatment may be advised in more s... What is localised scleroderma. Scleroderma.

Patient information leaflet
Muscle weakness
Parkinson's disease ... Those who have these conditions may become wheelchair-bound. Sarcoidosis Sarcoidosis : This is a rare disease in which clumps of cells (granulomas) form in skin, lungs and soft tissues, including muscles. The condition usually goes away after a few years but can become more progressive in some people. Amyloidosis involves.

Patient information leaflet
Mastocytosis and mast cell disorders
A mast cell is a type of white blood cell. There are several forms of mastocytosis. In one, there are too many mast cells in the body: in another the number of mast cells is normal but they are too active. What are mast cells. Mast cells are a type of white blood cell - together, our white blood cells play a major role in our immune system,.

Patient information leaflet
Myeloma
Myeloma is a cancer that affects cells, called plasma cells, in the bone marrow. Bone marrow is the spongy tissue at the centre of some bones that produces the body's. Hyperviscosity This means that the blood may become too thick due to a v... If you develop these symptoms then you need to seek medical advice without delay. Amyloidosis This is an.

Patient information leaflet
Discoid lupus
Discoid lupus is a rare skin condition but it is very long-lasting. It is usually sensitive to sunlight and causes scarring when the lesions heal. What is discoid lupus. Discoid lupus is an uncommon but long-lasting (chronic) skin rash, which is usually made worse by exposure to sunlight (it is photosensitive). Discoid lupus is also called discoid.

Patient information leaflet
Eye problems
This leaflet contains a list of conditions which affect the eye, grouped together by the part of the eye which is affected or involved. See the leaflet called Anatomy of the eye for details on the structure of the eye Anatomy of the eye. Sjögren's syndrome Subconjunctival haemorrhage This is a common cause of painless red eye, which looks very.
Further reading and references
- Primary localized cutaneous amyloidosis; MedlinePlus, National Library of Medicine.
- Arita K, South AP, Hans-Filho G, Sakuma TH, Lai-Cheong J, Clements S, Odashiro M, Odashiro DN, Hans-Neto G, Hans NR, Holder MV, Bhogal BS, Hartshorne ST, Akiyama M, Shimizu H, McGrath JA. Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis. Am J Hum Genet. 2008 Jan;82(1):73-80. doi: 10.1016/j.ajhg.2007.09.002.
- Chang YT, Lin CH, Lee CT, Lin MW, Liu LY, Chen CC, Lee DD, Liu HN, Tsai SF, Matsuura I. Detection of common mutations in sporadic primary localized cutaneous amyloidosis by DNA mass spectrometry. Br J Dermatol. 2014 Apr;170(4):974-6. doi: 10.1111/bjd.12733. No abstract available.
- Chang YT, Wong CK, Chow KC, Tsai CH. Apoptosis in primary cutaneous amyloidosis. Br J Dermatol. 1999 Feb;140(2):210-5. doi: 10.1111/j.1365-2133.1999.02651.x.
- Hermanns HM. Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology. Cytokine Growth Factor Rev. 2015 Oct;26(5):545-58. doi: 10.1016/j.cytogfr.2015.07.006. Epub 2015 Jul 3.
- Kaltoft B, Schmidt G, Lauritzen AF, Gimsing P. Primary localised cutaneous amyloidosis--a systematic review. Dan Med J. 2013 Nov;60(11):A4727.
- Lin MW, Lee DD, Liu TT, Lin YF, Chen SY, Huang CC, Weng HY, Liu YF, Tanaka A, Arita K, Lai-Cheong J, Palisson F, Chang YT, Wong CK, Matsuura I, McGrath JA, Tsai SF. Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis. Eur J Hum Genet. 2010 Jan;18(1):26-32. doi: 10.1038/ejhg.2009.135.
- Tanaka A, Arita K, Lai-Cheong JE, Palisson F, Hide M, McGrath JA. New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis. Br J Dermatol. 2009 Dec;161(6):1217-24. doi: 10.1111/j.1365-2133.2009.09311.x. Epub 2009 May 26.
- Vijaya B, Dalal BS; Sunila; Manjunath GV. Primary cutaneous amyloidosis: a clinico-pathological study with emphasis on polarized microscopy. Indian J Pathol Microbiol. 2012 Apr-Jun;55(2):170-4. doi: 10.4103/0377-4929.97853.
- Wali A, Liu L, Takeichi T, Jelani M, Rahman OU, Heng YK, Thng S, Lee J, Akiyama M, McGrath JA, Betz RC. Familial primary localized cutaneous amyloidosis results from either dominant or recessive mutations in OSMR. Acta Derm Venereol. 2015 Nov;95(8):1005-7. doi: 10.2340/00015555-2104. No abstract available.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

